Insider Trading Summary for Intra-Cellular Therapies, Inc. (ITCI): Year

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
27-Feb-24 7:57 PM View:	26-Feb-24 Option Sale ($1.81M)	Marcus Joel S Director		Intra-Cellular Therapies, Inc. - ITCI	27% 39.23K to 49.66K	0	0	--	--	Show Txns Hide Txns

02-Apr-24 4:15 PM View:	31-Mar-24 Grant $5.47K	van Nostrand Robert L Director		Intra-Cellular Therapies, Inc. - ITCI	4% 9.35K to 9.69K	0	0	--	--	Show Txns Hide Txns

02-Apr-24 4:15 PM View:	31-Mar-24 Grant $17.99K	Riggs Rory B Director		Intra-Cellular Therapies, Inc. - ITCI	27% 78.36K to 99.5K	0	0	--	--	Show Txns Hide Txns

11-Mar-24 8:31 PM View:	11-Mar-24 Sale (Planned) ($481.93K)	Neumann Mark EVP, Chief Commercial Officer		Intra-Cellular Therapies, Inc. - ITCI	(34%) 45.34K to 29.7K	0	0	--	--	Show Txns Hide Txns

11-Mar-24 8:32 PM View:	11-Mar-24 Sale (Planned) ($484.54K)	Halstead Michael EVP and General Counsel		Intra-Cellular Therapies, Inc. - ITCI	0% --	0	0	--	--	Show Txns Hide Txns

11-Mar-24 8:31 PM View:	11-Mar-24 Sale (Planned) ($184.78K)	Durgam Suresh K. EVP, Chief Medical Officer		Intra-Cellular Therapies, Inc. - ITCI	(14%) 23.1K to 19.8K	0	0	--	--	Show Txns Hide Txns

11-Mar-24 8:33 PM View:	11-Mar-24 Sale (Planned) ($368.19K)	Hineline Lawrence J. SVP of Finance, CFO		Intra-Cellular Therapies, Inc. - ITCI	0% --	0	0	--	--	Show Txns Hide Txns

25-Apr-24 5:08 PM View:	24-Apr-24 Option Exercise $345.62K	Mates Sharon Chairman and CEO Director		Intra-Cellular Therapies, Inc. - ITCI	(7%) 1.15M to 1.07M	0	0	--	--	Show Txns Hide Txns

Buy:	0	--
Sell:	0	--